Investor Relations

Home > Investor Relations > IR Library > Balance Sheets (consolidated)

Balance Sheets (consolidated)

(million yen) 
  FY2017
(2017/4/1-2018/3/31)
FY2018
(2018/4/1-2019/3/31)
(Assets)
Current assets
   
Cash and deposits 14,247 26,762
Notes and accounts receivable 24,185 27,905
Electronically recorded monetary claims 6,278 6,719
Marketable securities 10,999 4,999
Finished products 17,609 17,591
Interim products 9,777 6,504
Raw materials and stored goods 8,951 13,858
Currency swaps 506 1,651
Other current assets 2,006 2,260
Allowance for doubtful accounts 363 48
Total current assets 94,200 108,206
Fixed assets    
Buildings and structures (net) 34,722 47,376
Machineries, equipments and carriers (net) 12,807 11,913
Land 9,803 11,078
Constructions in progress 18,282 2,110
Other tangible fixed assets (net) 1,372 1,184
Total tangible fixed assets 76,989 73,663
Intangible fixed assets 1,936 1,470
Investments    
Investment securities 427 451
Stock of subsidiaries and associates 54 199
Deferred tax assets 1,032 1,246
Net defined benefit asset 36 31
Others 2,508 3,536
Allowance for doubtful accounts 5 0
Total investments and other assets 4,054 5,463
Total fixed assets 82,980 80,597
Total assets 177,181 188,803

(million yen) 
  FY2017 FY2018
(Liabilities)
Current liabilities
   
Trade notes and accounts payable 5,385 6,466
Electronically recorded obligations-operating 6,412 9,990
Short-term debt 850 850
Current portion of long-term debt 4,249 6,396
Accrued expenses 5,351 6,205
Accrued income taxes 2,766 4,204
Accrued bonuses for directors and Auditors 95 82
Notes payable-equipment 6,246 1,391
Accounts payable-equipment 2,384 677
Other current liabilities 2,162 912
Total current liabilities 35,904 37,177
Long-term liabilities    
Convertible bond 15,046 15,035
Long-term debt 44,803 43,407
Net defined benefit liability 287 -
Accrued retirement benefits for directors and Auditors 128 14
Other long-term liabilities 1,091 1,398
Total long-term liabilities 61,356 59,854
Total liabilities 97,260 97,032
(Net Assets)
Shareholders' equity
   
Capital stock 4,717 4,717
Capital surplus 7,870 7,870
Retained earnings 72,816 84,734
Treasury stock 5,639 5,640
Total shareholders' equity 79,765 91,682
Other accumulated comprehensive income    
Difference on revaluation of marketable securities 147 88
Remeasurements of defined benefit plans 7 -
Total other accumulated comprehensive income 155 88
Total net assets 79,920 91,771
Total liabilities and net assets 177,181 188,803

Home > Investor Relations > IR Library > Balance Sheets (consolidated)
© Copyright TOWA PHARMACEUTICAL CO.,LTD. All Rights Reserved.